Navigation Links
Health Care and Security: What Americans Want from a Job
Date:1/3/2008

It's not just the money: New Center for Excellence poll finds Americans

want health insurance and security; pay ranks farther down list

WASHINGTON, Jan. 3 /PRNewswire-USNewswire/ -- A new poll shows that health insurance and security are at the top of Americans' list of desirables in a job, while pay ranked much lower.

The national poll, conducted by Princeton Survey Research Associates for the Center for State and Local Government Excellence, surveyed 1,200 adults age 18 and older.

Whether security comes from health insurance, job security, the promise of a retirement income, or clear work policies, Americans want a lot more than just a paycheck from their employment.

Given a list of 15 benefits and characteristics that may be important in choosing a job:

-- 84 percent of Americans ranked health insurance at the very top.

-- Job security and clear policies and procedures (82 percent each) were

ranked next in importance; the retirement or pension plan (76 percent);

and a flexible, family-friendly workplace in fifth place (71 percent).

-- Pay ranked tenth with 65 percent, trailing such matters as getting

quick decisions on issues (69 percent); working with talented managers

(68 percent); having the potential for promotions (66 percent); and

being creative and intellectually stimulated (66 percent).

In another key set of findings, Americans say state and local government jobs offer better benefits, job security, and chance to make a contribution to society, while jobs in the private sector offer better opportunities for innovation, greater chances to work with the best people, and better opportunities for promotion. They are divided on which sector offers the best compensation.

The poll, which surveyed participants by landline and cellular phone within the continental United States from October 24-November 4, 2007, had an overall margin of sampl
'/>"/>

SOURCE Center for State and Local Government Excellence
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Hologic to Present at the 26th Annual JP Morgan Healthcare Conference
2. ASPS Studies Re-Evaluate Psychological Benefits and Health Concerns of Silicone Breast Implants
3. Health Department Warns Consumers of Home-Canned Soup Linked to Potter County Restaurant
4. VIDEO from Medialink and Revolution Health: RevolutionHealth.com Launches Resolutions 2.0
5. Neurochem to present at JPMorgan Healthcare Conference
6. Boston Scientific to Participate in JP Morgan Health Care Conference
7. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
8. Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
9. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
10. Health Departments Slow to Respond to Disease Outbreaks
11. AUDIO from Medialink and Pharmavite: Holiday Heart Health Tips
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... site www.sleeping-with-a-sleeping-disorder.com is asking people ,who ... sleep aids from around the world to donate ... The submissions will be compiled in an ebook ... to be sold from the website in early ... the proceeds ,from sales of the E-book to ...
(Date:12/5/2009)... shown in a phase 1/2 clinical trial that ... of patients newly diagnosed with multiple myeloma, a cancer ... from Dana-Farber Cancer Institute. , Partial responses or better ... with the drug combination in the multi-center study, with ... in the phase 2 population, reports Paul G. Richardson, ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
(Date:12/5/2009)... experts advise , , SATURDAY, Dec. 5 (HealthDay News) -- ... can have bad reactions to certain holiday traditions and ... wheezing, according to the American College of Allergy, Asthma ... live evergreens may choose to decorate with artificial plants, ...
(Date:12/5/2009)... today announced the launch of International Solutions, an innovative new international ... its UK equivalent. In addition to offering customers the flexibility to ... needs and budgets, International Solutions enables customers to tailor their benefits ... , ...
Breaking Medicine News(10 mins):Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:AVIVA's Private Health Insurance Products Solutions Go International 2
... 8 Anpath Group, Inc.,(OTC Bulletin Board: ANPG), ... reported several advancements with,the introduction of EquineTru(R). The ... product line with the market launch of,EquineTru(R), an ... at the Atlanta Fall Classic Horse Show., ...
... MBF Healthcare,Acquisition Corp. (AMEX: MBH ), ... that it will host an investor,conference call on ... time to,discuss the recently announced signing of a ... Inc. (along with its,subsidiaries, "CHS"). Hosting the call ...
... (Nasdaq:,STXS), announced today that Bevil J. Hogg, Chief ... will present at the Deutsche Bank,Small- and Mid-Cap ... Naples,Florida on Thursday, February 14, 2008 at 2:40 ... is by invitation only. The audio,presentation will be ...
... of Breast Cancer Movement Gathers Record Attendance for Annual ... ... Susan G. Komen for the Cure(R), the,world,s largest and most ... annual Affiliate Leadership,Conference Feb. 7-9 at the Hilton Anatole in Dallas. ...
... Feb. 7 ORBIS International is,saddened to announce ... the board of,directors, the Honorable Oliver Foot. He ... ), Oliver,s dedication to reduce human ... with ORBIS, a nonprofit global development,organization that transcends ...
... in Past Three Years and Fourth Consecutive Quarterly ... Revenue Increase Over Prior Year, ... of BioZ(R) Impedance Cardiography (ICG),technology, today reported financial results for its ... and do not include,results for Vermed which was sold on August ...
Other Medicine News:Health News:Anpath Group, Inc. Announces Advancements with Animal Care Line 2Health News:Anpath Group, Inc. Announces Advancements with Animal Care Line 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 4Health News:Susan G. Komen for the Cure(R) Hosts Annual Affiliate Leadership Conference in Dallas 2Health News:Susan G. Komen for the Cure(R) Hosts Annual Affiliate Leadership Conference in Dallas 3Health News:ORBIS International Announces the Death of the Honorable Oliver Foot, President and Board Member 2Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 2Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 3Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 4Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 5Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 6Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 7
(Date:12/4/2009)... 4 Bayer Diabetes Care today announced the three grand ... Nick Jonas, of the Jonas Brothers, selected the winning video ... The grand prize is an in-person meeting today with Nick. ... like Nick, are: Caleb, age 6, from Danbury, CT, who ...
(Date:12/4/2009)... Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin ... Trademark Office has allowed its patent application on a ... manufacture of the Company,s DCVax® therapeutic cancer vaccines. ... high concentration of dendritic cells (which are the critical ...
(Date:12/4/2009)... anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder ... the comorbidities reported to occur more often in ... epilepsy versus those without an epilepsy diagnosis, according ... the U.S. ,, Findings from " CNS-Related Comorbidities ...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3TV Spotlight on DataDeed and Living Will Solutions 57725 1TV Spotlight on DataDeed and Living Will Solutions 57725 2Radiological treatment method spares patients surgery and offers 89 percent cost savings 57721 1Surgeon Battling Own Cancer Developed New Treatment 57718 1Surgeon Battling Own Cancer Developed New Treatment 57718 2Surgeon Battling Own Cancer Developed New Treatment 57718 3
... from CHARM Study in Remission at One Year ... Maintained Remission at Two ... an,open-label extension study of two Abbott pivotal studies, CHARM and ... long-term clinical remission and clinical,response, respectively, according to data presentations ...
... Alba Therapeutics Corporation,announced today that data from ... Clinical Advances in Celiac Disease session at the ... Results of the randomized,double- blind, placebo controlled study ... reactivation by gluten challenge in celiac,subjects in remission(1) ...
Other Medicine Technology:Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 2Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 3Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 4Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 5Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 6Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 7Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 2Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 3Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 4Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 5
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
Medicine Products: